234 related articles for article (PubMed ID: 17047382)
1. Carney complex: pathology and molecular genetics.
Boikos SA; Stratakis CA
Neuroendocrinology; 2006; 83(3-4):189-99. PubMed ID: 17047382
[TBL] [Abstract][Full Text] [Related]
2. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit (PRKAR1A) in patients with the "complex of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas" (Carney complex).
Stratakis CA
Ann N Y Acad Sci; 2002 Jun; 968():3-21. PubMed ID: 12119264
[TBL] [Abstract][Full Text] [Related]
3. Carney complex: the first 20 years.
Boikos SA; Stratakis CA
Curr Opin Oncol; 2007 Jan; 19(1):24-9. PubMed ID: 17133108
[TBL] [Abstract][Full Text] [Related]
4. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex.
Kirschner LS; Carney JA; Pack SD; Taymans SE; Giatzakis C; Cho YS; Cho-Chung YS; Stratakis CA
Nat Genet; 2000 Sep; 26(1):89-92. PubMed ID: 10973256
[TBL] [Abstract][Full Text] [Related]
5. Pathology and molecular genetics of the pituitary gland in patients with the 'complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas' (Carney complex).
Stratakis CA; Matyakhina L; Courkoutsakis N; Patronas N; Voutetakis A; Stergiopoulos S; Bossis I; Carney JA
Front Horm Res; 2004; 32():253-64. PubMed ID: 15281351
[TBL] [Abstract][Full Text] [Related]
6. Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the carney complex.
Kirschner LS; Sandrini F; Monbo J; Lin JP; Carney JA; Stratakis CA
Hum Mol Genet; 2000 Dec; 9(20):3037-46. PubMed ID: 11115848
[TBL] [Abstract][Full Text] [Related]
7. Male infertility as a component of Carney complex.
Wieacker P; Stratakis CA; Horvath A; Klose S; Nickel I; Buhtz P; Muschke P
Andrologia; 2007 Oct; 39(5):196-7. PubMed ID: 17714219
[TBL] [Abstract][Full Text] [Related]
8. Use of mouse models to understand the molecular basis of tissue-specific tumorigenesis in the Carney complex.
Kirschner LS
J Intern Med; 2009 Jul; 266(1):60-8. PubMed ID: 19522826
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase A alterations in endocrine tumors.
Yu B; Ragazzon B; Rizk-Rabin M; Bertherat J
Horm Metab Res; 2012 Sep; 44(10):741-8. PubMed ID: 22752956
[TBL] [Abstract][Full Text] [Related]
10. [Clinical features and pathogenesis of Carney complex, a rare form of multiple endocrine neoplasia syndromes].
Igaz P; Rácz K; Szabolcs Z; Tulassay Z
Orv Hetil; 2006 Mar; 147(12):551-5. PubMed ID: 16696379
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of the Carney complex gene 1 (protein kinase A regulatory subunit 1A) inhibits SMAD3 expression and TGF beta-stimulated apoptosis in adrenocortical cells.
Ragazzon B; Cazabat L; Rizk-Rabin M; Assie G; Groussin L; Fierrard H; Perlemoine K; Martinez A; Bertherat J
Cancer Res; 2009 Sep; 69(18):7278-84. PubMed ID: 19738044
[TBL] [Abstract][Full Text] [Related]
12. Adrenal pathophysiology: lessons from the Carney complex.
Groussin L; Cazabat L; René-Corail F; Jullian E; Bertherat J
Horm Res; 2005; 64(3):132-9. PubMed ID: 16192737
[TBL] [Abstract][Full Text] [Related]
13. PRKAR1A mutations in primary pigmented nodular adrenocortical disease.
Cazabat L; Ragazzon B; Groussin L; Bertherat J
Pituitary; 2006; 9(3):211-9. PubMed ID: 17036196
[TBL] [Abstract][Full Text] [Related]
14. Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity.
Bertherat J; Groussin L; Sandrini F; Matyakhina L; Bei T; Stergiopoulos S; Papageorgiou T; Bourdeau I; Kirschner LS; Vincent-Dejean C; Perlemoine K; Gicquel C; Bertagna X; Stratakis CA
Cancer Res; 2003 Sep; 63(17):5308-19. PubMed ID: 14500362
[TBL] [Abstract][Full Text] [Related]
15. Clinical and molecular genetics of Carney complex.
Sandrini F; Stratakis C
Mol Genet Metab; 2003 Feb; 78(2):83-92. PubMed ID: 12666684
[TBL] [Abstract][Full Text] [Related]
16. Regulatory subunit type I-alpha of protein kinase A (PRKAR1A): a tumor-suppressor gene for sporadic thyroid cancer.
Sandrini F; Matyakhina L; Sarlis NJ; Kirschner LS; Farmakidis C; Gimm O; Stratakis CA
Genes Chromosomes Cancer; 2002 Oct; 35(2):182-92. PubMed ID: 12203783
[TBL] [Abstract][Full Text] [Related]
17. Molecular and immunohistochemical investigation of protein kinase a regulatory subunit type 1A (PRKAR1A) in odontogenic myxomas.
Perdigão PF; Stergiopoulos SG; De Marco L; Matyakhina L; Boikos SA; Gomez RS; Pimenta FJ; Stratakis CA
Genes Chromosomes Cancer; 2005 Oct; 44(2):204-11. PubMed ID: 16001434
[TBL] [Abstract][Full Text] [Related]
18. 17q22-24 chromosomal losses and alterations of protein kinase a subunit expression and activity in adrenocorticotropin-independent macronodular adrenal hyperplasia.
Bourdeau I; Matyakhina L; Stergiopoulos SG; Sandrini F; Boikos S; Stratakis CA
J Clin Endocrinol Metab; 2006 Sep; 91(9):3626-32. PubMed ID: 16772351
[TBL] [Abstract][Full Text] [Related]
19. Molecular cloning, chromosomal localization of human peripheral-type benzodiazepine receptor and PKA regulatory subunit type 1A (PRKAR1A)-associated protein PAP7, and studies in PRKAR1A mutant cells and tissues.
Liu J; Matyakhina L; Han Z; Sandrini F; Bei T; Stratakis CA; Papadopoulos V
FASEB J; 2003 Jun; 17(9):1189-91. PubMed ID: 12692076
[TBL] [Abstract][Full Text] [Related]
20. Evidence that PKA activity is constitutively activated in human GH-secreting adenoma cells in a patient with Carney complex harbouring a PRKAR1A mutation.
Takano K; Yasufuku-Takano J; Morita K; Mori S; Takei M; Osamura RY; Teramoto A; Fujita T
Clin Endocrinol (Oxf); 2009 May; 70(5):769-75. PubMed ID: 19178533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
